Immunotherapy Resumption/Rechallenge in Melanoma Patients after Toxicity: Do We Have Another Chance?

Introduction: Immune checkpoint inhibitors (ICIs) have radically changed the prognosis of several neoplasias, among them metastatic melanoma. In the past decade, some of these new drugs have appeared together with a new toxicity spectrum previously unknown to clinicians, until now. A common situatio...

Descripción completa

Detalles Bibliográficos
Autores principales: España Fernandez, Sofia, Sun, Chen, Solé-Blanch, Carme, Boada, Aram, Martínez-Cardús, Anna, Manzano, José Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052939/
https://www.ncbi.nlm.nih.gov/pubmed/36986683
http://dx.doi.org/10.3390/pharmaceutics15030823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052939/
https://www.ncbi.nlm.nih.gov/pubmed/36986683
http://dx.doi.org/10.3390/pharmaceutics15030823

Ejemplares similares